Segment Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Segment Wealth Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $303,043 - $333,756	-4,173 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $15,677 - $18,798	-255 Reduced 5.76%	4,173 $305,000
Q4 2021 Jan 24, 2022	BUY	$53.63 - $62.52 $237,473 - $276,838	4,428 New	4,428 $276,000
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $188,870 - $221,237	-3,192 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$61.91 - $67.42 $197,616 - $215,204	3,192 New	3,192 $213,000
Q1 2020 Apr 24, 2020	SELL	$46.4 - $67.43 $191,771 - $278,688	-4,133 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $203,384 - $265,297	4,133 New	4,133 $265,000
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $477,457 - $619,148	-9,792 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $1,048 - $1,182	-19 Reduced 0.19%	9,792 $608,000
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $8,438 - $10,517	-167 Reduced 1.67%	9,811 $543,000
Q4 2017 Jan 23, 2018	SELL	$59.94 - $65.35 $31,048 - $33,851	-518 Reduced 4.94%	9,978 $611,000
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $203,135 - $234,435	3,678 Added 53.95%	10,496 $669,000
Q2 2017 Aug 11, 2017	BUY	N/A	6,818	6,818 $380,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Segment Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Segment Wealth Management, LLC with notifications on news.